Novo Nordisk A/S ADR buy Morgan Stanley
Start price
23.01.24
/
50%
€95.40
Target price
23.01.25
€110.32
Performance (%)
26.95%
Price
30.04.24
€120.50
Summary
This prediction is currently active. The prediction currently has a performance of 26.95%. Dividends of €0.61 are taken into consideration when calculating the performance. This prediction currently runs until 23.01.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | 0.000% | 0.000% |
| iShares Core DAX® | -1.370% | -3.231% |
| iShares Nasdaq 100 | 0.172% | -3.339% |
| iShares Nikkei 225® | -0.801% | -7.859% |
| iShares S&P 500 | -0.369% | -2.979% |
Comments by Morgan_Stanley for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $120.00 price target on the stock.
Ratings data for NVO provided by MarketBeat